Cita APA

Gutiérrez-Chamorro, L., Felip, E., Castellà Fernández, E., Quiroga García, V., Ezeonwumelu, I., Angelats, L., . . . Ballana, E. (2023). SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer.

Citación estilo Chicago

Gutiérrez-Chamorro, Lucía|||0000-0002-7649-951X, et al. SAMHD1 Expression Is a Surrogate Marker of Immune Infiltration and Determines Prognosis After Neoadjuvant Chemotherapy in Early Breast Cancer. 2023.

Cita MLA

Gutiérrez-Chamorro, Lucía|||0000-0002-7649-951X, et al. SAMHD1 Expression Is a Surrogate Marker of Immune Infiltration and Determines Prognosis After Neoadjuvant Chemotherapy in Early Breast Cancer. 2023.